MCC
VRTX icon

Malaga Cove Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Malaga Cove Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
2,405
-186
-7% -$82.4K 0.38% 71
2026
Q1 		$1.16M Buy
2,591
+119
+5% +$55.5K 0.42% 71
2025
Q4 		$1.12M Sell
2,472
-162
-6% -$69.8K 0.39% 81
2025
Q3 		$1.03M Buy
2,634
+722
+38% +$302K 0.37% 80
2025
Q2 		$851K Buy
1,912
+123
+7% +$56.7K 0.33% 84
2025
Q1 		$867K Sell
1,789
-200
-10% -$93.2K 0.37% 75
2024
Q4 		$801K Buy
+1,989
New +$922K 0.31% 84
2021
Q4 		– Sell
-7,905
Closed -$1.43M – 184
2021
Q3 		$1.43M Buy
7,905
+50
+0.6% +$9.76K 0.59% 57
2021
Q2 		$1.58M Buy
7,855
+2,332
+42% +$488K 0.68% 51
2021
Q1 		$1.19M Buy
5,523
+855
+18% +$188K 0.51% 69
2020
Q4 		$1.08M Buy
4,668
+1,781
+62% +$409K 0.51% 75
2020
Q3 		$786K Buy
2,887
+26
+0.9% +$7.17K 0.46% 81
2020
Q2 		$831K Buy
2,861
+70
+3% +$19K 0.51% 81
2020
Q1 		$663K Sell
2,791
-907
-25% -$208K 0.54% 74
2019
Q4 		$810K Hold
3,698
– – 0.5% 76
2019
Q3 		$627K Buy
+3,698
New +$654K 0.42% 95

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Malaga Cove Capital's VRTX Position: Q2 2026 in Review

Malaga Cove Capital reduced its Vertex Pharmaceuticals (VRTX) stake by 7.2% in Q2 2026, selling an estimated $82.4K and leaving 2,405 shares worth $1.19M. The position accounts for 0.38% of the portfolio, ranked #71.

Malaga Cove Capital first reported a position in VRTX in Q3 2019 and has held it in 16 quarters since. The position peaked at $1.58M in Q2 2021. 1,754 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Malaga Cove Capital held 2,405 shares of Vertex Pharmaceuticals worth $1.19M as of Q2 2026.
  • Malaga Cove Capital sold 186 Vertex Pharmaceuticals shares in Q2 2026, an estimated $82.4K.
  • Vertex Pharmaceuticals made up 0.38% of Malaga Cove Capital's portfolio in Q2 2026, its #71 holding.
  • Malaga Cove Capital first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 16 quarters since.
  • Malaga Cove Capital's Vertex Pharmaceuticals position peaked at $1.58M in Q2 2021.
  • 1,754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Malaga Cove Capital's 13F filing for Q2 2026, filed 24 Jul 2026.